Weight Loss & Metabolic

Liraglutide

GLP-1 receptor agonist ยท Saxenda/Victoza (branded)

A once-daily GLP-1 receptor agonist used for weight management and type 2 diabetes.

Overview & Mechanism

Activates GLP-1 receptors to increase glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite.

Research Dosage

Dose

Titrate 0.6 mg โ†’ 1.2 mg โ†’ 1.8 mg โ†’ 3.0 mg once daily

Route

Subcutaneous injection

Frequency

Once daily

Cycle

12+ weeks

Reconstitution & Storage

Reconstitution

Comes pre-formulated in pens; for research vials, reconstitute per concentration with bacteriostatic water.

Storage

Refrigerate 2โ€“8 ยฐC. Do not freeze.

Safety & Side Effects

Nausea, vomiting common. Contraindicated in MTC/MEN 2.

Studies

SCALE Obesity Trial (liraglutide 3.0 mg)

Liraglutide 3.0 mg daily plus lifestyle produced 8.0% weight loss over 56 weeks versus 2.6% with placebo.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.